Stamp D, Juliano R L
Can J Physiol Pharmacol. 1979 May;57(5):535-9. doi: 10.1139/y79-081.
The reported efficiencies of drug encapsulation into liposomes range from less than 0.1% to more than 10% per micromole phospholipid, depending on the nature of the drug and of the liposome employed. We have sought to investigate some of the factors which control the efficiency of drug encapsulation. We have found that most polar drugs are sequestered within the internal aqueous compartment of the liposomes, while nonpolar drugs can bind to the liposome membrane in addition to being sequestered, thus accounting for their higher efficiencies of encapsulation. The encapsulation of nonpolar drugs, but not of polar drugs, is very sensitive to the physical characteristics of the liposome membrane; in particular, a fluid membrane favors the efficient encapsulation of nonpolar compounds. The drug cytosine arabinoside is anomalous in that this highly polar compound seems to interact with the liposome membrane at physiological conditions of pH and ionic strength, thus allowing it to be encapsulated with high efficiency.
据报道,每微摩尔磷脂将药物包封到脂质体中的效率范围从低于0.1%到超过10%,这取决于所用药物和脂质体的性质。我们试图研究一些控制药物包封效率的因素。我们发现,大多数极性药物被隔离在脂质体的内部水相中,而非极性药物除了被隔离外,还能与脂质体膜结合,因此其包封效率更高。非极性药物(而非极性药物)的包封对脂质体膜的物理特性非常敏感;特别是,流动性膜有利于非极性化合物的高效包封。药物阿糖胞苷是个例外,因为这种高极性化合物在生理pH和离子强度条件下似乎与脂质体膜相互作用,从而使其能够高效包封。